Mechanism of action
Trihexyphenidyl belongs to agents that inhibit cholinergic transmission in the central nervous system. Its primary target is the $M_1$ muscarinic receptors of the neostriatum. By blocking them, the drug restores the disturbed balance between the dopaminergic and cholinergic systems characteristic of parkinsonism. An important pharmacological advantage over classical atropine is that trihexyphenidyl acts predominantly within the CNS, making its peripheral effects significantly less pronounced.
Pharmacological effects
The drug exhibits moderate antiparkinsonian activity. Clinically, it primarily and selectively suppresses tremor (shaking) and reduces muscle rigidity (stiffness). However, it is important to remember a clinical nuance: trihexyphenidyl has little effect on bradykinesia (slowness of movement).
Indications for use
Like its derivative biperiden, trihexyphenidyl is prescribed for the following extrapyramidal disorders:
- Parkinson's disease (primarily in the early stages of the disease).
- Parkinsonism syndrome of various etiologies.
- Drug-induced parkinsonism is a specific indication for this group. The drug is used to prevent and relieve extrapyramidal symptoms caused by antipsychotics (neuroleptics).
Side effects and overdose
Adverse reactions are classified according to their mechanism of occurrence (localization of the blocked receptors):
- Peripheral (resulting from peripheral muscarinic receptor blockade): dry mouth (xerostomia), constipation, tachycardia (palpitations), urinary retention, and cycloplegia (impaired near vision).
- Central (resulting from central muscarinic receptor blockade): cognitive impairment, including memory loss and decreased concentration. Elderly patients are at particularly high risk as they are most sensitive to central side effects.
In case of overdose, acute psychosis develops: psychomotor agitation and hallucinations (so-called anticholinergic delirium).
Contraindications
Given its pronounced anticholinergic profile, the drug is strictly contraindicated in:
- Glaucoma (due to the risk of increased intraocular pressure).
- Prostatic hyperplasia (high risk of acute urinary retention).
- Lactation period (breastfeeding).
- Individual hypersensitivity.
Prescription rules and dosages
The drug is available in tablets of 0.001 g (1 mg), 0.002 g (2 mg), and 0.005 g (5 mg). Administered orally with meals. The standard single dose is 0.001–0.002 g.
- Maximum Single Dose (MSD): 0.01 g.
- Maximum Daily Dose (MDD): 0.02 g.
Prescription example: Rp.: Tab. Cyclodoli 0.002 D.t.d. N. 50 S. Take one tablet orally with meals.
Briefly: answers to topical questions
How does trihexyphenidyl affect gastrointestinal tone and motility?
In the cited sources, the effect of trihexyphenidyl on gastrointestinal tone and motility is not directly described. Constipation and dry mouth are listed as peripheral side effects of biperiden, which is pharmacologically related to trihexyphenidyl.
Cyclodol focuses in the CNS: blocks the Center (neostriatum), inhibits Tremor, but scrambles Memory.
Class and exam questions
Why is trihexyphenidyl preferred over atropine in parkinsonism?
Trihexyphenidyl is a central muscarinic antagonist. Unlike atropine, it acts predominantly in the CNS, causing significantly fewer peripheral side effects (such as dry mouth or tachycardia).
How does the drug affect the main symptoms of Parkinson's disease?
It effectively reduces tremor and muscle rigidity, yet has virtually no effect on bradykinesia.
What is a specific indication for central anticholinergic agents?
Relief and prevention of drug-induced parkinsonism (extrapyramidal symptoms) that occurs as a side effect of neuroleptic therapy.
Why is the drug prescribed with caution in the elderly?
Elderly patients are most sensitive to central side effects of anticholinergic drugs, primarily cognitive impairment (memory loss and decreased concentration).
What else to study on this topic
- Comparative profile of trihexyphenidyl and biperiden
- Mechanism of drug-induced parkinsonism during neuroleptic therapy
- Dopamine receptor agonists (bromocriptine) in the treatment of parkinsonism
- Principles of combination therapy with levodopa and peripheral decarboxylase inhibitors
- Anticholinergic syndrome: clinical presentation and emergency management in overdose
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on 'Trihexyphenidyl' and 5,304 other pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the «Drugs and Prescriptions» section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.